Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tagamet HB TV ad claiming "full prescription strength" enjoined by district court.

This article was originally published in The Tan Sheet

Executive Summary

TAGAMET HB TV AD CLAIMING Rx STRENGTH HEARTBURN TREATMENT PROHIBITED by federal court Judge Harold Baer in an April 24 bench decision. The N.Y. Southern District Court judge determined that the SmithKline Beecham ad claims -- that Tagamet HB is the only approved OTC H2 antagonist available in "full prescription strength" and that "nothing stops stomach acid faster" -- are "misleading" and possibly claims of "literal falsity."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel